Stay updated on Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page
- ChecktodayChange DetectedA new revision label, v3.5.4, is added to the record history, replacing the previous v3.5.3 entry. This reflects an update to the record's versioning without changing the underlying data.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s interface/version footer was updated from revision v3.5.2 to v3.5.3, reflecting a minor maintenance release to ClinicalTrials.gov rather than a change to the underlying study record.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision v3.5.2 was added and Revision v3.5.0 was removed.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision label in the page footer was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.4.2 was added, replacing the previous v3.4.1 label on the history page.SummaryDifference0.0%

Stay in the know with updates to Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.